Joseph Schwarz, Chief Scientist of AlphaRx, will make an oral podium presentation of GAI-122 injectable nanoemulsion for neuroprotection. The results conclude that, based on the neuroprotective properties of GAI-122 and the increased focus of GAI-122 in the brain after parenteral delivery relative to oral dosing, it is affordable to expect that an injectable form of GAI-122 based on a nanoemulsion, provides the mandatory protection against harm to behavioral and cognitive features in human beings experiencing various ischemic disorders.. AlphaRx reports positive preclinical outcomes of GAI-122 injectable nanoemulsion for Acute Ischemic Stroke AlphaRx, Inc. announced positive preclinical results of GAI-122 injectable nanoemulsion, a Mitochondria-targeted neuroprotective medication candidate being developed for the treating Acute Ischemic Stroke.Health Alliance Medical Plans is one of the two highest ranked HMO/POS plans in Illinois with a ranking of 4 out of 5 in the National Committee of Quality Assurance Private MEDICAL HEALTH INSURANCE Plan Ratings, 2015-2016. Health Alliance is also one of the best four Medicare HMOs in Illinois with a rating of 4.5 out of 5 in NCQA's Medicare MEDICAL HEALTH INSURANCE Plan Ratings, 2015-2016. Beck, MD, FAPA, Wellness Alliance Vice Chief and President Medical Officer. Catasys offers a distinctive plan, which we believe is a great complement to our services and adds significant value for our users who have problems with medical and behavioral conditions. We are thrilled to have the ability to begin offering OnTrak for Health Alliance's eligible insured commercial fully, Medicare Advantage and Medicaid members.

Other articles from category "mycology":

Random articles